摘要
[目的 ]探讨阿卡波糖和甲福明治疗 2型糖尿病的经济效果。 [方法 ]根据文献数据 ,对 6 0例 2型糖尿病患者分别用阿卡波糖和甲福明治疗的临床效果进行成本效果分析。 [结果 ]阿卡波糖、甲福明的总成本分别为 34 2 .7和 71.82元 ;对空腹血糖的降低效果分别为 83%、87% ;对餐后血糖的治疗效果分别为 97%、73%。 [结论 ]从药物经济学的角度来看 ,降低空腹血糖以甲福明为佳 ;
To evaluate the economic effectiveness in treatment of type-2 diabetes mellitus with acarbose and metformin . The data from literature about 60 patients with type-2 diabetes mellitus given by acarbose or metformin were evaluated with cost-effectiveness analysis method. The cost of acarbose and metforrmin were RMB 342.7 and 105.72 respectively, the benefits were 83% and 87% respectively for treating fasting blood glucose, and 97% and 73% respectively for treating postprandial blood glucose. [CONCLUSION] Metformine is better for decreasing fasting blood glucose, and acarbose is better for decreasing postprandial blood glucose.
出处
《药学进展》
CAS
2002年第1期39-41,共3页
Progress in Pharmaceutical Sciences
关键词
阿卡波糖
甲福明
药物经济学
成本效果分析
2型糖尿病
Acarbose
Metformin
Pharmacoeconomics
Cost-effectiveness analysis
Type-2 diabetes mellitus
